Recent advancements in biotechnology have seen the emergence of a breakthrough cancer vaccine developed by Moderna and Merck, leveraging artificial intelligence (AI). This innovative vaccine is reportedly designed to alter cancer treatment paradigms. According to the...
Moderna and Merck have announced the positive results of a late-stage clinical trial for a personalised mRNA vaccine designed to combat melanoma. This new development suggests a significant reduction in the recurrence and spread of this...